What Clinicians Need to Know About Chronic GVHD and Immunity

In this episode of ASTCT Talks, supported by an educational grant from Sanofi US, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, sits down with Dr. Sanjeet Singh Dadwal, MD, chief of infectious diseases at City of Hope, to explore a critical aspect of chronic graft-versus-host disease (GVHD): immune dysfunction and infection risk.

The discussion highlights:

• How chronic GVHD independently contributes to immune deficits and infection susceptibility.

• Infectious risks associated with FDA-approved therapies for chronic GVHD.

• Common infections in this population and why vigilance matters.

• Practical guidance on prophylaxis strategies, vaccination timing, and navigating real-world challenges like food safety.

This episode offers actionable insights for clinicians managing infection prevention and survivorship care in patients with chronic GVHD.

Read “Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors,” included in the 2024 GVHD Supplement collection published by Transplantation and Cellular Therapy.